Roche launches new treatment options for women with metastatic breast cancer in India

October 2015
Express Pharma;10/12/2015, p1
The article discusses the Indian subsidiary of the Switzerland based Roche Group, Roche Products (India) Private Limited's launch of two new drugs Perjeta and Kadcyla for treatment of HER2-positive metastatic breast cancer in women.


Related Articles

  • Pushing patches. Fox, Marisa // Harper's Bazaar;Apr95, Issue 3401, p80 

    Reports on the popularity of prescription patches. Skincare patches; Attraction of medical component; Diagnostic and therapeutic patches; Studies on skin application of substances.

  • Anastrozole.  // Reactions Weekly;Nov2015, Vol. 1576 Issue 1, p34 

    The article presents a case study of a 41-year-old female patient suffering from metastatic breast cancer after administration of anastrazole.

  • Piqray New Treatment Approved for Metastatic Breast Cancer and PI3KCA Mutation.  // Oncology Practice Management;Jun2019, Vol. 9 Issue 6, p40 

    No abstract available.

  • Supporting Teenage Children Whose Mothers Have Metastatic Breast Cancer. SHOCKNEY, LILLIE D. // Oncology Practice Management;Jun2019, Vol. 9 Issue 6, p50 

    No abstract available.

  • Palbociclib/ribociclib: Neutropenia: 6 case reports.  // Reactions Weekly;6/29/2019, Vol. 1759 Issue 1, p206 

    The article describes the case of six women, aged 39-76 years, who experienced neutropenia during treatment with palbociclib or ribociclib for metastatic breast cancer.

  • Docetaxel/pertuzumab/trastuzumab: Allergy: case report.  // Reactions Weekly;7/13/2019, Vol. 1761 Issue 1, p144 

    No abstract available.

  • Ileal carcinoid tumor represents after prolonged remission as a solitary breast mass. Principe, Daniel R; Raicu, Andreea; Bergsten, Tova M; Rubin, Jonathan; Hagen, Colleen // Journal of Surgical Case Reports;Jun2019, Vol. 2019 Issue 6, p1 

    While the metastatic spread of breast cancer is well documented, the breast is seldom a site for metastasis. Non-mammillary cancers can involve the breast or axilla, though this is exceedingly rare with few reported instances. Here, we present the case of a 62-year-old woman who attended an...

  • JWT/Bridge wins China's first gold at Clios for Roche. Savage, Mike // Media: Asia's Media & Marketing Newspaper;6/3/2005, p5 

    This article reports that the headache pill Saridon advertisement made by JWT-Bridge Advertising Co. for Shanghai Roche Pharmaceuticals Co. Ltd. has won the 2005 Cilo Awards, first ever for China. The campaign was described by Tom Doctoroff, JWT's North Asia's area director, as a mobilizing call...

  • Doxorubicin.  // Reactions Weekly;2/20/2016, Vol. 1589 Issue 1, p88 

    An abstract of the article "Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin" by G. Pahouja and others is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics